Literature DB >> 1465755

Respiratory disease in systemic lupus erythematosus: correlation with results of laboratory tests and histological appearance of muscle biopsy specimens.

S A Evans1, N D Hopkinson, W J Kinnear, L Watson, R J Powell, I D Johnston.   

Abstract

BACKGROUND: In systemic lupus erythematosus, certain laboratory tests and evidence from muscle biopsy specimens of lymphocytic vasculitis reflect disease activity. A study was designed to determine if such indices predict respiratory lesions, and in particular whether the presence of vasculitis in quadriceps muscle reflects respiratory muscle function.
METHODS: Twenty seven 27 patients with systemic lupus erythematosus were studied, ten of whom were consecutive untreated patients and 17 having clinically active disease and being treated. They were prospectively evaluated on the basis of erythrocyte sedimentation rate, lymphocyte count, C3 degradation products, quadriceps muscle biopsy, spirometry, lung volumes, carbon monoxide transfer factor, and mouth pressure during a maximal sniff.
RESULTS: Lung function test results were abnormal in 12 patients. Vital capacity was reduced in seven, carbon monoxide transfer factor capacity in five, and mouth pressure was low (< 70% predicted) in ten. Lymphocytic vasculitis was seen in the muscle biopsy specimens of ten patients. No correlation was found between laboratory tests and lung function or mouth pressure, or between the presence of lymphocytic vasculitis and mouth pressure. In untreated patients, those with lymphocytic vasculitis had lower spirometric values.
CONCLUSIONS: In systemic lupus erythematosus, evidence from muscle biopsy specimens of lymphocytic vasculitis is not predictive of impaired inspiratory muscle function as measured by mouth pressure. In untreated patients there were relationships between some laboratory test results and respiratory function, but this was not the case for the whole group. In systemic lupus erythematosus, laboratory tests and evidence from muscle biopsy specimens of lymphocytic vasculitis are therefore unlikely to be helpful in the assessment of respiratory disease.

Entities:  

Mesh:

Year:  1992        PMID: 1465755      PMCID: PMC464109          DOI: 10.1136/thx.47.11.957

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  27 in total

1.  "UNEXPLAINED" DYSPNOEA AND SHRINKING LUNGS IN SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  B I HOFFBRAND; E R BECK
Journal:  Br Med J       Date:  1965-05-15

2.  Prognostic indices in lupus nephritis.

Authors:  B Hecht; N Siegel; M Adler; M Kashgarian; J P Hayslett
Journal:  Medicine (Baltimore)       Date:  1976-03       Impact factor: 1.889

3.  Phrenic nerve function in patients with diaphragmatic weakness and systemic lupus erythematosus.

Authors:  P G Wilcox; H B Stein; S D Clarke; P D Paré; R L Pardy
Journal:  Chest       Date:  1988-02       Impact factor: 9.410

4.  Duration and death in systemic lupus erythematosus. An analysis of 249 cases.

Authors:  E L Dubois; M Wierzchowiecki; M B Cox; J M Weiner
Journal:  JAMA       Date:  1974-03-25       Impact factor: 56.272

5.  Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction.

Authors:  J B Winfield; C M Brunner; D Koffler
Journal:  Arthritis Rheum       Date:  1978-04

6.  Serum immune complexes and disease activity in lupus nephritis.

Authors:  R J Levinsky; J S Cameron; J F Soothill
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

7.  The maximal sniff in the assessment of diaphragm function in man.

Authors:  J M Miller; J Moxham; M Green
Journal:  Clin Sci (Lond)       Date:  1985-07       Impact factor: 6.124

8.  Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus.

Authors:  C M Laroche; D A Mulvey; P N Hawkins; M J Walport; B Strickland; J Moxham; M Green
Journal:  Q J Med       Date:  1989-05

9.  Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance.

Authors:  S J Rivero; E Díaz-Jouanen; D Alarcón-Segovia
Journal:  Arthritis Rheum       Date:  1978-04

10.  Pulmonary function of nonsmoking patients with systemic lupus erythematosus.

Authors:  A P Andonopoulos; S H Constantopoulos; V Galanopoulou; A A Drosos; N C Acritidis; H M Moutsopoulos
Journal:  Chest       Date:  1988-08       Impact factor: 9.410

View more
  2 in total

1.  Urticarial skin lesions and polymyositis due to lymphocytic vasculitis.

Authors:  N L Kao; H J Zeitz
Journal:  West J Med       Date:  1995-02

2.  Muscle biopsy abnormalities in systemic lupus erythematosus: correlation with clinical and laboratory parameters.

Authors:  K L Lim; R Abdul-Wahab; J Lowe; R J Powell
Journal:  Ann Rheum Dis       Date:  1994-03       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.